Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation scheme. [electronic resource]
Producer: 19920225Description: 603-9 p. digitalISSN:- 0008-5472
- Anthraquinones -- pharmacokinetics
- Antineoplastic Agents -- pharmacokinetics
- Blood Proteins -- metabolism
- Carbon Radioisotopes
- Drug Evaluation
- Glomerular Filtration Rate -- drug effects
- Humans
- Metabolic Clearance Rate
- Neoplasms -- drug therapy
- Orosomucoid -- metabolism
- Protein Binding
- Pyrazoles -- pharmacokinetics
- Pyrazolones
- Regression Analysis
- Tissue Distribution
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.